Skip to main content
PGEN logo

Precigen, Inc.

PGENNASDAQHealthcareBiotechnology

$6.04Today:- (-)1Y +50.35%

As of Oct 26, 2026 close

Market cap
$2.50B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.04$8.98
Volume (live)
-
Avg. volume (3M)
5.33M

Precigen (PGEN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Precigen used $87.83M of cash in operating activities and spent $2.00M on capital expenditures. That left free cash flow of −$89.83M. It repurchased $3.08M of its own shares.

Precigen Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Precigen, Inc. (PGEN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-250.64-126.24-95.9028.32-92.17-170.52-170.52-514.71-126.82
Depreciation & Amortization3.204.536.6710.7713.7617.5217.5233.1131.15
Deferred Income Tax0.00-1.80-0.48-0.15-0.17-0.16-0.16-21.28-2.53
Stock Based Compensation11.3910.029.8910.2113.9018.3718.3746.9952.69
Change in Working Capital6.622.6617.07-35.70-0.80-20.65-20.65-19.99-74.58
Change in Accounts Receivable-3.200.4112.23-13.51-6.564.334.33-2.700.74
Change in Inventory-9.210.000.002.34-1.902.512.51-0.480.66
Change in Accounts Payable8.771.55-2.420.380.42-1.10-1.104.68-3.40
Change in Other Working Capital-1.26-0.82-13.07-24.916.51-26.39-26.39-21.49-72.58
Other Operating Activities141.6040.85-13.07-78.486.5178.4378.43351.6315.95
Net Cash from Operating Activities-87.83-68.17-66.93-65.05-55.77-77.02-77.02-124.24-104.14
Investing Activities
Capital Expenditures-2.00-8.58-1.54-4.92-7.25-7.53-7.53-41.59-46.67
Acquisitions0.000.000.000.000.000.00-10.83-14.90-23.35
Purchases of Investments-208.01-187.21-185.030.00-174.22-171.36-171.36-178.68-1.16
Sales/Maturities of Investments208.47175.02183.3868.44100.17133.00133.0066.19174.78
Other Investing Activities0.000.060.10162.906.7673.6784.5017.770.74
Net Cash from Investing Activities-1.54-20.71-3.09226.42-74.5427.7827.78-151.21104.33
Financing Activities
Debt Repayment92.820.00-43.22-155.29-0.47-2.41-2.41219.47-0.78
Common Stock Issued0.8531.5872.810.00121.0535.0035.0087.9913.69
Common Stock Repurchased-3.080.000.000.000.000.000.000.000.00
Other Financing Activities-2.2079.350.000.000.610.120.122.34-8.62
Net Cash from Financing Activities90.05110.5829.59-155.29121.1932.7132.71309.804.28
Summary
Effect of Forex Changes on Cash0.04-0.03-0.32-0.830.220.350.350.301.03
Net Change in Cash0.7221.67-40.755.25-9.12-16.18-16.1834.645.50
Cash at Beginning of Period29.527.8548.6043.3452.2568.4368.4375.5562.61
Cash at End of Period30.2329.527.8548.6043.3452.2552.25110.1868.11
Free Cash Flow-89.83-76.76-68.47-69.97-63.02-84.55-84.55-165.83-150.81
Supplemental Disclosures
Interest Paid-0.011.178.547.167.20---
Income Taxes Paid-0.000.02-0.040.05---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Precigen Cash Flow

What is Precigen's free cash flow?

Precigen had negative free cash flow of $89.83M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$87.83M minus $2.00M of capital expenditures.

How much does Precigen spend on capital expenditures?

Precigen spent $2.00M on capital expenditures in fiscal 2025, compared with $8.58M a year earlier.

Does Precigen pay dividends or buy back shares?

Yes. In fiscal 2025 Precigen returned $3.08M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition